Claim/exemption information - Registry number 9452
List of suggested corrective measures
Correct administrative non-compliances.
Disclose a statement conveying that the antidote to poisoning by the product must be administered only under the supervision of a physician.
Disclose an acceptable ACGIH (TWA, STEL, C) value for each of the confidential ingredients “Inorganic base” and “Polyhydric alcohol”.
Disclose eye contact as a likely route of exposure.
Disclose that the product may cause reproductive toxicity effect.
Disclose the LD50 (rat, oral) value of 205 mg/kg and the LD50 (rabbit, dermal) value >1 260 mg/kg and <2 000 mg/kg for the confidential ingredient “Inorganic base”. Disclose the LD50 (rat, oral) value of 1 700 mg/kg for the confidential ingredient “Polyhydric alcohol”.
Disclose the additional hazard classifications of “Reproductive Toxicity – Category 2”, “Specific Target Organ Toxicity-Single Exposure (STOT-SE) – Category 1 (oral, CNS and kidney due to acidosis)” and “Acute Toxicity (Oral) – Category 4”.
Disclose the additional information elements concerning hazard and precautionary statements.
Disclose the additional symbols and/or names of symbols for “Reproductive Toxicity – Category 2”, “STOT-SE – Category 1” and “Acute Toxicity (Oral) – Category 4”.
Disclose the calculated product oral ATE of 550 mg/kg (0% unknown) and dermal ATE of 3 400 mg/kg (0% unknown).
Disclose the initial boiling point and boiling range.
Disclose the other hazards known to the supplier, including a clear definition of the acronyms “PBT” and “vPvB”.
Disclose the percent of unknown toxicity of 0% for the calculated product oral ATE value.
Disclose the reactivity.
Disclose unsuitable extinguishing media for the product.